Irinotecan combined with infusional 5-FU [fluorouracil]/folinic acid or capecitabine and the role of celecoxib in patients with metastatic colorectal cancer

Trial Profile

Irinotecan combined with infusional 5-FU [fluorouracil]/folinic acid or capecitabine and the role of celecoxib in patients with metastatic colorectal cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Sep 2012

At a glance

  • Drugs Capecitabine; Celecoxib; Fluorouracil; Folinic acid; Irinotecan
  • Indications Colorectal cancer
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Most Recent Events

    • 21 Sep 2012 Last checked against ClinicalTrials.gov record.
    • 01 May 2008 Results published in the Annals of Oncology.
    • 30 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top